Klogene Therapeutics, Inc. Company
Klogene is developing therapeutics for prevention and treatment of age related diseases based on increasing the level of the naturally occurring Klotho protein in the human body
Industry:
BioTech
Investors Number:
8
Technology:
Immunotherapy
Last Funding Type:
Pre-Seed
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2015-01-01
Investor Type:
For Profit
Funding Status:
Seed
Total Funding:
1800000
Estimated Revenue:
$1M to $10M
Employee Number:
11-50